CPS neonatal Flashcards
signs of neonatatal hypoglycemia (9)
jitteriness, termors episodes of cyanosis seizures apneic spells, tachypnea weak or high pitched cry limp lethargy difficulty feeding episodes of sweating, sudden pallor hypothermia cardiac arrest
who do you screen neonatal hypoglycemia
LGA, SGA, IDM, preterm
when hypoglycemic?
@ 2hrs
< 1.8 - IV rx
< 2 - feed and recheck
@> 2hrs
< 2 - IV rx
< 2.6 - refeed and recheck
GOOD
> 2 at 2hrs of age
> 2.6 at subsequent checks
Rx neonatal symptomatic hypoglycemia
Target > 2.6mmol/L
IV bolus 2ml/kg D10W IV infusion D10 @ 80ml/kg/hr = GIR 5.5mg/kg/min GIR = Infusion(ml/hr) x Dext/(6xkg) - investigations +/- specialist referral IV glucagon 0.1-0.3mg/kg or IV glucagon infusion 10-20mcg/kg/hr
risk factors neonatal sepsis
GA < 36 chorioamnionitis (Fever, WBC, foul, uterine tenderness) PROM > 18hrs previous GBS sepsis GBS bacturia this pregnancy
name common bacteria in neonatal sepsis & gram stain
gram+ cocci: GBS
gram+ rods: listeria
gram-cocci: uncommon
gram-rods:e.coli, kleb, pseudomonas
ROP screening recommendations
all infants < 31 weeks or BW < 1250g
if < 28 weeks –> screen at cGA31weeks
if 28 weeks –> screen at PNA 4 weeks
ROP when to treat?
zone 1 - stage 3 or any stage with plus disease
zone 2 - stage 2/3 with plus disease
laser photocoagulation
cyrotherapy
intravitreal injection of VEGF
what is acute bilirubin encephalopathy
clinical syndrome in setting of severe hyperbili, lethargy, hypotonia, poor suck that can progress to hypertonia (opsthotonos), high pitched cry and fever, to seizures and coma
rare unless TSB > 425umol/L (critical)
severe is > 340umol/L
what is considered elevated direct hyperbilirubinemia?
> 18umol/L Or > 20% of TSB
natural history of jaundice
term - peak 3-5days
preterm peak 5 - 7 days
pathological - within 24hrs of life
risk factors progression of severe hyperbili 8
GA < 38 weeks isoimmune hemolytic disease G6PD asphyxia respiratory distress lethargy temp instability sepsis acidosis
indication for exchange transfusion.
How to do
clinical signs of acute bilirubin encephalophaty
if despite photorx, TSB 375-425umol/L
double volume exchange (body=80ml/kg)
central cath placement
remove and replace aliquots of 10% blood volume
expect 1/2 fall. replace 85% blood circulating RBC
irradiated blood - reduce GvHD
s/e exchange transfusion
blood-borne infection thrombocytopenia, coagulopathy GvHD Nec Portal vein thrombosis electrolyte - hypoCa, hyperK cardiac arrhythmias
partial exchange transfusion
for polycythemia using N/S
exchange volume = (obs Hct - desired hct) x blood volume / observed hct
post natal corticosteroids - indications
after discuss with parents:
high risk of CLD or prolonged ventilator dependence or severe severe CLD
- low dose (initial 0.15-2mg/kg/day) tapering doses over 7 - 10 day course
ICS alternative but unknown duration/dose/effectiveness
caution with AI esp if sepsis/nec etc.
s/e post natal steroid
early < 7 days of life
- increased rate of CP, death
hyperglycemia, HTN, GI hemorrhage, GI perforation
late > 7 days of life
- high incidence of HOCM, severe ROP
why ancephalic baby not recommended for organ donation?
not usually satisfy brain death criteria as brain stem function
by time death declared, often with ischemic changes and inappropriate
use of life support not improve chances of successful organ donation
Vitamin K prophylaxis - doses
IM >/= 1.5kg = 1mg x 1
(all within 6hr after birth)
PO @ first feed, 1mo, 2mo = 3x 2mg doses
both does not provide complete protection, but IM > PO for late HDNB
Hemorrhagic disease of the newborn
- types
early HDNB - within 24hrs of life - expectant moms if impaired VitK metabolism classic (first 3 weeks of life) - rare if given vit K infant late HDNB (3-8weeks of life) - almost exclusively in infants BF - IM > PO - IM failure rate 0.25/100,000 infants
circumcision adverse effects
pain, minor bleed, local infection
unsatisfactory cosmetic result
late: meatal stenosis (2-10%)
contraindications to circumscision
hypospadias
bleeding disorder
benefits of circumscision (3)
phimosis treatment UTI reduction STI reduction - decrease new HIV by 50-60^ HPV cancer reduction
universial hearing screen targets
target screening by 1 month
confirm diagnosis by 3mo
intervention by 6 moths
risk factors SNHL (6)
FmHx permanent hearing loss cranofacial - ie external ear Congenital infection (bact meningitis, CMV, Toxo, Rubella, CMV, herpes, syphilis) Syndrome associated with SNHL NICU > 2 days ECMO assisted ventilation ototoxic drug hyperbili needing exchange
Types of hearing screen
OAE - otoacustic emission first test without risk factors
AABR - automated auditory brainstem response - those who not pass OAE or RF
Limitations of OAE and AABR
both for >24hr, min 34cGA
both affected by infant movement, environemntal nose, dysfunction in middle/external ear
BOTH detects from mod hearing loss only (30-40dB)
OAE
- conductive and cochlear hearing loss
AABR
- conductive, cochlear, neural (CN8)
benefits earlier hearing screen
early detection = improved receptive and expressive language scrore
cochlear implants between 8-12months and auditory roral therapy possible
Cost-effectivesness
false positive 2 - 4%
CPS FASD types
alcohol related birth defects
alcohol related neurodevelopmental defects
vs FASD guidelines 2015 CMAJ
- FASD with sentinel facial features
- FASD without sentinel facial features